Abstract: A diagnostic method includes the following steps. A step of detecting values of an acceleration of a vibration of a building floor. A step of calculating vibration information related to the vibration of the building floor based on a detection signal. The vibration information includes frequencies and magnitudes of the vibration. A step of performing a vibration diagnosis of a structural body of a diagnosis model based on the first vibration information, an index related to a vibration of the structural body, and information on a display device. The index is a standard of the vibration allowed for the structural body. The displayed information identifies a plurality of supports that are candidates for a first support installed between the building floor and the structural body. A step of outputting a first diagnosis result of the vibration diagnosis to the display device.

Abstract: The present invention relates to a method for detecting a target substance that is useful for detection of a glycoprotein and the like comprising a specific sugar chain, a reagent for detecting a target substance, a carrier and a method for manufacturing the carrier.

Abstract: The present invention relates to a method for detecting a target substance that is useful for detection of a glycoprotein and the like comprising a specific sugar chain, a reagent for detecting a target substance, a carrier and a method for manufacturing the carrier.

Abstract: A diagnostic system calculates first vibration information related to a vibration of an installation location based on the detection signal detected by an inertial sensor disposed at an installation location, and generates a first diagnostic result based on a first support selected from candidates, and the first vibration information.

Abstract: A branching unit branches a first wavelength-multiplexed optical signal input through a first transmission line, the first wavelength-multiplexed optical signal including first and second optical signals. A wavelength selection unit receives the branched first wavelength-multiplexed optical signal branched by the branching unit, receives a second wavelength-multiplexed optical signal including a third optical signal in the same band as that of the first optical signal and a fourth optical signal in the same band as that of the second optical signal through a second transmission line, outputs a third wavelength-multiplexed optical signal including the first and fourth optical signals optical to a third transmission line and output the third optical signal.

Abstract: A branching unit branches a first wavelength-multiplexed optical signal input through a first transmission line, the first wavelength-multiplexed optical signal including first and second optical signals, A wavelength selection unit receives the branched first wavelength-multiplexed optical signal branched by the branching unit, receives a second wavelength-multiplexed optical signal including a third optical signal in the same band as that of the first optical signal and a fourth optical signal in the same band as that of the second optical signal through a second transmission line, outputs a third wavelength-multiplexed optical signal including the first and fourth optical signals optical to a third transmission line and output the third optical signal.

Abstract: An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a reagent for quantitative determination of a glycoprotein, which is used for the above measurement methods. Furthermore, an object of the present invention is to provide a glycan-marker glycoprotein as an index for clinical conditions of liver disease, which is capable of identifying the clinical conditions of liver disease depending on the progress of liver disease.

Abstract: The present invention relates to a method for detecting a target substance that is useful for detection of a glycoprotein and the like comprising a specific sugar chain, a reagent for detecting a target substance, a carrier and a method for manufacturing the carrier.

Abstract: An object of the present invention is to provide an electrophotographic photosensitive body having improved electrophotographic characteristics such as sensitivity and residual potential and also having excellent durability. The present invention provides an electrophotographic photosensitive body having a layer containing at least one specific p-terphenyl compound and at least one polycarbonate resin represented by the general formula (I): in a mass ratio of the p-terphenyl compound to the polycarbonate resin within the range of 2:8 to 7:3.

Abstract: An object of the invention is to provide a method of making a p-terphenyl compound mixture which includes two symmetric p-terphenyl compounds respectively represented by formula (1) and formula (2) and an asymmetric p-terphenyl compound represented by formula (3)

Abstract: An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a reagent for quantitative determination of a glycoprotein, which is used for the above measurement methods. Furthermore, an object of the present invention is to provide a glycan-marker glycoprotein as an index for clinical conditions of liver disease, which is capable of identifying the clinical conditions of liver disease depending on the progress of liver disease.

Abstract: An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Disclosed is a method for measuring at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject, comprising: measuring AGP binding to a first lectin selected from AOL and MAL, when the glycoprotein is AGP; and measuring M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII, when the glycoprotein is M2BP.

Abstract: An object of the invention is to provide a method of making a p-terphenyl compound mixture which includes two symmetric p-terphenyl compounds respectively represented by formula (1) and formula (2) and an asymmetric p-terphenyl compound represented by formula (3)

Abstract: An object of the present invention is to provide an electrophotographic photosensitive body having improved electrophotographic characteristics such as sensitivity and residual potential and also having excellent durability. The present invention provides an electrophotographic photosensitive body having a layer containing at least one specific p-terphenyl compound and at least one polycarbonate resin represented by the general formula (I): in a mass ratio of the p-terphenyl compound to the polycarbonate resin within the range of 2:8 to 7:3.

Abstract: An object of the invention is to provide: a p-terphenyl compound mixture useful as a charge-transporting agent which has improved solubility in organic solvents to thereby diminish a cracking phenomenon, which poses problems concerning photoreceptor characteristics, and can realize an electrophotographic photoreceptor having high sensitivity and high durability; and an electrophotographic photoreceptor employing the compound mixture. The invention relates to: a p-terphenyl compound mixture which includes two symmetric p-terphenyl compounds respectively represented by the following general formula (1) and general formula (2) and an asymmetric p-terphenyl compound represented by the following general formula (3) which has both a group of substituents of the compound represented by general formula (1) and a group of substituents of the compound represented by general formula (2); and an electrophotographic photoreceptor containing the compound mixture.

Abstract: An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Disclosed is a method for measuring at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject, comprising: measuring AGP binding to a first lectin selected from AOL and MAL, when the glycoprotein is AGP; and measuring M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII, when the glycoprotein is M2BP.

Abstract: An object of the present invention is to provide an electrophotographic photosensitive body which is not impaired in electrophotographic characteristics such as charged potential and residual potential, and which is also excellent in repeating stability. The present invention provides an electrophotographic photosensitive body including a conductive support having thereon a layer containing a specific p-terphenyl compound and at least one additive.

Abstract: A method for the early detection of disease through the use of reagents bound by IgM antibodies is described. A reagent and method for the detection of anti-Borna disease virus antibodies are also described.

Abstract: The present invention relates to an immunoassay apparatus comprising a measurement unit 2 for measuring a HIV antibody amount and a HIV antigen amount in a specimen and an analysis means 400 for analyzing on HIV infection based on a measurement result which is outputted from the measurement unit 2. The analysis means 400 includes a false-positive detection means for detecting false-positive as a result of a HIV infection test, and the false-positive detection means detects false-positive when the HIV antibody amount is within a range of weak-positive and the HIV antigen amount is within a range of negative.

Abstract: An object of the present invention is to provide an electrophotographic photosensitive body having improved electrophotographic characteristics such as sensitivity and residual potential and also having excellent durability. The present invention provides an electrophotographic photosensitive body having a layer containing at least one specific p-terphenyl compound and at least one polycarbonate resin represented by the general formula (I): in a mass ratio of the p-terphenyl compound to the polycarbonate resin within the range of 2:8 to 7:3.